The in vitro antimicrobial activity of tobramycin and gentamicin was compared against 362 (3, 5, 6, 10, 13, 14, 18 
Tobramycin, a new aminoglycoside antibiotic separated from the nebramycin antibiotic complex, has been found to have greater in vitro activity than gentamicin against Pseudomonas species, as well as a wide spectrum of activity against the Enterobacteriaceae and Staphylococcus aureus (3, 5, 6, 10, 13, 14, 18) . The clinical importance of Pseudomonas infections in the hospital setting (1, 11) and reports of gentamicin-resistant strains of Pseudomonas (16) and other Enterobacteriaceae (20) prompted this comparative study of the activity of tobramycin and gentamicin against gram-negative organisms and S. aureus.
MATERIALS AND METHODS
Organisms. Pseudomonas, Proteus, Escherichia coli, Klebsiella-Enterobacter, and staphylococcal organisms tested in this study were 
RESULTS
In vitro susceptibility of various microorganisms to tobramycin and gentamicin. The relative susceptibility of various microorganisms to tobramycin is shown in Fig. 1 sistant to one antibiotic tended also to be resistant to the other. One strain isolated from a chronically infected skin ulcer was highly resistant to both tobramycin (MIC, 500 ,Ag/ml) and gentamicin (MIC > 3,000 ,g/ml). The patient had not received gentamicin or tobramycin prior to isolation of this organism.
In contrast to Pseudomonas strains, S. marcescens was generally more susceptible to gentamicin (mean MIC, 0.34 ± 0.14 isg/ml) than to tobramycin (mean MIC, 2.25 ± 5.02 ,g/ml; Fig.  2 ). No consistent differences in the susceptibility to tobramycin and gentamicin were seen for E. coli, Klebsiella-Enterobacter, Proteus species (indole-positive and indole-negative strains), and S. aureus.
Comparison of MIC with disc diffusion susceptibility tests. Zones of inhibition around 10-,Ag tobramycin discs for each strain of bacteria were determined with the same overnight culture used for the MIC testing (Fig. 3) (Fig. 4) .
When the inoculum size was increased from a 10-4 to a 10-2 dilution of an overnight culture, 11 (Fig. 5) . At the acid pH, the tobramycin MIC values were twofold greater for all strains tested than at neutral pH. At alkaline pH, the tobramycin MIC was twofold higher for all five Pseudomonas species tested, two of three Proteus strains, and two of four E. coli strains. The remaining three strains showed no differences. These data suggest that tobramycin was most effective at a neutral pH.
DISCUSSION
These in vitro studies demonstrated that tobramycin was consistently more active than gentamicin against Pseudomonas species. The relative susceptibility of Pseudomonas to tobramycin and gentamicin paralleled each other, but the MIC for most Pseudomonas strains was consistently fourfold lower for tobramycin than for gentamicin. A single strain highly resistant to gentamicin was also resistant to tobramycin. Against three Pseudomonas strains for which the MIC of gentamicin was 10 ,g/ml, the MIC of tobramycin was less than 5,ug/ml. Our findings are consistent with earlier published reports comparing these antibiotics (3-6, 10, 14, 18) .
We chose the 5-,ug level as the cut-off point for susceptibility to gentamicin because most reported studies of the clinical pharmacology of gentamicin indicate that the usual intramuscular dose of 1.5 mg/kg gives a mean peak concentration in serum of 5 to 7,g/ml (8, 9, 19) . Among recent clinical isolates of Pseudomonas in our institutions, 22% showed a gentamicin MIC in the 5 to 10 ,ug/ml range, a level we would consider relatively resistant. In contrast, the MIC of tobramycin for the majority of these Pseudomonas strains was below 1.25 ,g/ml. The susceptibility threshold for tobramycin was originally proposed by Preston and Wick (14) to be 8 ,ug/ml; however, Shadomy The antimicrobial activity of tobramycin against Enterobacteriaceae and S. aureus is similar to that of gentamicin. This finding would suggest that tobramycin could be utilized in place of gentamicin in patients with suspected gram-negative sepsis. Only in the rare clinical situation of S. marcescens infection do our in vitro data suggest a disadvantage in using tobramycin in place of gentamicin.
The diameter of the tobramycin and gentamicin zone of inhibition was found to vary significantly with the media employed. The size of the zone around gentamicin discs has been shown to vary with the concentration in the media of calcium and magnesium ions (7) . The variation of the magnesium ion concentration had the greatest effect on the gentamicin MIC values and zone diameters (7, 12 half the concentration of magnesium ions. This variation in the zone diameter has application to the usual clinical practice of determining susceptibility and resistance by predetermined zone diameters. The size of the zone used to distinguish tobramycin resistance and susceptibility must not only specify the media but also the magnesium and calcium ion concentration.
